I‐Ying Kuo

798 total citations
24 papers, 520 citations indexed

About

I‐Ying Kuo is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, I‐Ying Kuo has authored 24 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in I‐Ying Kuo's work include Epigenetics and DNA Methylation (8 papers), RNA modifications and cancer (6 papers) and Cancer-related gene regulation (5 papers). I‐Ying Kuo is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), RNA modifications and cancer (6 papers) and Cancer-related gene regulation (5 papers). I‐Ying Kuo collaborates with scholars based in Taiwan, Macao and Japan. I‐Ying Kuo's co-authors include Yi‐Ching Wang, Wu‐Wei Lai, Wei‐Lun Chang, Wu‐Chou Su, Pei‐Jung Lu, Hung‐Chi Cheng, Jia‐Ming Chang, Bor‐Shyang Sheu, Yulin Huang and Hong‐Tai Tzeng and has published in prestigious journals such as Nature Communications, Bioinformatics and Oncogene.

In The Last Decade

I‐Ying Kuo

23 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I‐Ying Kuo Taiwan	14	357	123	109	94	70	24	520
Shunlin Jiang United States	10	349 1.0×	137 1.1×	104 1.0×	59 0.6×	41 0.6×	14	499
Jian‐Liang Chou Taiwan	11	333 0.9×	118 1.0×	72 0.7×	58 0.6×	46 0.7×	21	480
Yong Gu China	10	324 0.9×	181 1.5×	100 0.9×	51 0.5×	50 0.7×	14	469
Byul A Jee South Korea	10	303 0.8×	128 1.0×	59 0.5×	40 0.4×	60 0.9×	10	445
Shao‐Lan Qin China	13	269 0.8×	140 1.1×	179 1.6×	93 1.0×	53 0.8×	26	482
Nicole P. Ho Hong Kong	6	265 0.7×	213 1.7×	137 1.3×	65 0.7×	46 0.7×	9	453
Zhuoying Lin China	9	215 0.6×	91 0.7×	77 0.7×	71 0.8×	58 0.8×	16	362
Leili Saeednejad Zanjani Iran	13	273 0.8×	114 0.9×	201 1.8×	74 0.8×	102 1.5×	37	497
Alexander Hamm Germany	5	209 0.6×	91 0.7×	116 1.1×	88 0.9×	44 0.6×	9	385
Kazuaki Fushimi Japan	15	333 0.9×	131 1.1×	135 1.2×	52 0.6×	68 1.0×	22	486

Countries citing papers authored by I‐Ying Kuo

Since Specialization

Citations

This map shows the geographic impact of I‐Ying Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Ying Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Ying Kuo more than expected).

Fields of papers citing papers by I‐Ying Kuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Ying Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Ying Kuo. The network helps show where I‐Ying Kuo may publish in the future.

Co-authorship network of co-authors of I‐Ying Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Ying Kuo. A scholar is included among the top collaborators of I‐Ying Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Ying Kuo. I‐Ying Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Sheng‐Kai, I‐Ying Kuo, Chon‐Kit Chou, et al.. (2025). Deubiquitinating enzymes: Key regulators of ferroptosis and pyroptosis and novel targets for cancer intervention. International Journal of Biological Sciences. 21(9). 3993–4009. 1 indexed citations

Tzang, Bor‐Show, et al.. (2025). Impact of Oseltamivir and Diabetes Development. Pharmaceuticals. 18(1). 128–128.

Kuo, I‐Ying, et al.. (2024). Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer. Journal of Biomedical Science. 31(1). 20–20. 5 indexed citations

Lin, Pei‐Wen, Yao‐Hsiang Shih, Sheng‐Hui Lan, et al.. (2024). Revealing potential Rab proteins participate in regulation of secretory autophagy machinery. The Kaohsiung Journal of Medical Sciences. 40(7). 642–649. 3 indexed citations

Wang, Yating, Shu‐Yu Lin, I‐Ying Kuo, et al.. (2023). PTPN23 ubiquitination by WDR4 suppresses EGFR and c-MET degradation to define a lung cancer therapeutic target. Cell Death and Disease. 14(10). 671–671. 12 indexed citations

Chang, Wei‐Lun, et al.. (2022). Nutlin‐3 acts as a DNA methyltransferase inhibitor to sensitize esophageal cancer to chemoradiation. Molecular Carcinogenesis. 62(2). 277–287. 9 indexed citations

Kuan, Wen‐Hui, Wei‐Lun Chang, I‐Ying Kuo, et al.. (2022). Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma. Journal of Biomedical Science. 29(1). 90–90. 18 indexed citations

Kuo, I‐Ying, Hong‐Tai Tzeng, Hung‐Chi Cheng, et al.. (2021). Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment. Theranostics. 11(14). 7029–7044. 58 indexed citations

Yu, Minhua, Ya‐Chin Hou, Chih‐Peng Chang, et al.. (2021). Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy. Theranostics. 12(1). 340–361. 35 indexed citations

10.

Ding, Li-Yun, Ya‐Chin Hou, I‐Ying Kuo, et al.. (2020). Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer. Clinical Epigenetics. 12(1). 87–87. 13 indexed citations

11.

Kuo, I‐Ying, Liting Wu, Wen‐Hui Kuan, et al.. (2020). Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression. Theranostics. 10(22). 10001–10015. 24 indexed citations

12.

Kuo, I‐Ying, Yulin Huang, Chien‐Yu Lin, et al.. (2019). SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes. Journal of Biomedical Science. 26(1). 20–20. 34 indexed citations

13.

Liao, Shengyou, I‐Ying Kuo, Yuting Chen, et al.. (2019). AKT-mediated phosphorylation enhances protein stability and transcription activity of ZNF322A to promote lung cancer progression. Oncogene. 38(41). 6723–6736. 20 indexed citations

14.

Kuo, I‐Ying, Pei‐Jung Lu, Hong‐Tai Tzeng, et al.. (2018). Rab37 mediates exocytosis of secreted frizzled-related protein 1 to inhibit Wnt signaling and thus suppress lung cancer stemness. Cell Death and Disease. 9(9). 868–868. 30 indexed citations

15.

Huang, Kuang‐Tzu, I‐Ying Kuo, Ming‐Chao Tsai, et al.. (2017). Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma. Molecular Therapy — Nucleic Acids. 9. 274–283. 22 indexed citations

16.

Chang, Wei‐Lun, Wu‐Wei Lai, I‐Ying Kuo, et al.. (2016). A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma. Journal of Gastroenterology. 52(6). 705–714. 20 indexed citations

17.

Kuo, I‐Ying, et al.. (2016). A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations. Journal of Biomedical Science. 23(1). 58–58. 12 indexed citations

18.

Chang, Jia‐Ming, et al.. (2014). Deregulation of SLIT2-Mediated Cdc42 Activity Is Associated with Esophageal Cancer Metastasis and Poor Prognosis. Journal of Thoracic Oncology. 10(1). 189–198. 33 indexed citations

19.

Kuo, I‐Ying, Jia‐Ming Chang, Chung‐Hsing Chen, et al.. (2014). Prognostic CpG Methylation Biomarkers Identified by Methylation Array in Esophageal Squamous Cell Carcinoma Patients. International Journal of Medical Sciences. 11(8). 779–787. 29 indexed citations

20.

Cheng, Hung‐Chi, Yu‐Shiuan Wang, Pinpin Lin, et al.. (2014). Small GTPase Rab37 targets tissue inhibitor of metalloproteinase 1 for exocytosis and thus suppresses tumour metastasis. Nature Communications. 5(1). 4804–4804. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact